Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP439095.RAGUV2eRNrVSkLHNxSkLhx7SP0um8B7fSw4lK6P294sQ0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP439095.RAGUV2eRNrVSkLHNxSkLhx7SP0um8B7fSw4lK6P294sQ0130_assertion type Assertion NP439095.RAGUV2eRNrVSkLHNxSkLhx7SP0um8B7fSw4lK6P294sQ0130_head.
- NP439095.RAGUV2eRNrVSkLHNxSkLhx7SP0um8B7fSw4lK6P294sQ0130_assertion description "[Semiquantitative reverse transcriptase-PCR of genes involved in drug response, such as topoisomerase I, topoisomerase IIalpha, multidrug resistance 1 (MDR1), multidrug resistance-associated protein (MRP), lung resistance-related protein (LRP), and glutathione S-transferase pi (GSTpi), did not explain the variability in drug sensitivity between SCLC xenografts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP439095.RAGUV2eRNrVSkLHNxSkLhx7SP0um8B7fSw4lK6P294sQ0130_provenance.
- NP439095.RAGUV2eRNrVSkLHNxSkLhx7SP0um8B7fSw4lK6P294sQ0130_assertion evidence source_evidence_literature NP439095.RAGUV2eRNrVSkLHNxSkLhx7SP0um8B7fSw4lK6P294sQ0130_provenance.
- NP439095.RAGUV2eRNrVSkLHNxSkLhx7SP0um8B7fSw4lK6P294sQ0130_assertion SIO_000772 19823076 NP439095.RAGUV2eRNrVSkLHNxSkLhx7SP0um8B7fSw4lK6P294sQ0130_provenance.
- NP439095.RAGUV2eRNrVSkLHNxSkLhx7SP0um8B7fSw4lK6P294sQ0130_assertion wasDerivedFrom befree-20140225 NP439095.RAGUV2eRNrVSkLHNxSkLhx7SP0um8B7fSw4lK6P294sQ0130_provenance.
- NP439095.RAGUV2eRNrVSkLHNxSkLhx7SP0um8B7fSw4lK6P294sQ0130_assertion wasGeneratedBy ECO_0000203 NP439095.RAGUV2eRNrVSkLHNxSkLhx7SP0um8B7fSw4lK6P294sQ0130_provenance.